(0.11%) 5 245.00 points
(0.15%) 39 594 points
(0.11%) 18 234 points
(0.81%) $79.90
(1.26%) $2.33
(1.00%) $2 363.70
(1.13%) $28.69
(0.42%) $995.00
(0.09%) $0.928
(-0.08%) $10.86
(0.06%) $0.799
(-0.51%) $92.07
-1.30% $ 31.95
@ $49.33
Emitido: 14 feb 2024 @ 15:32
Retorno: -35.23%
Señal anterior: feb 14 - 10:03
Señal anterior:
Retorno: 2.08 %
Live Chart Being Loaded With Signals
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins...
Stats | |
---|---|
Volumen de hoy | 407 812 |
Volumen promedio | 734 664 |
Capitalización de mercado | 2.18B |
EPS | $-2.53 ( 2024-05-03 ) |
Próxima fecha de ganancias | ( $-1.410 ) 2024-05-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.28 |
ATR14 | $0.0370 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Berkowitz Noah | Buy | 93 879 | Stock Option (right to buy) |
2024-03-18 | Berkowitz Noah | Buy | 63 452 | Common Stock |
2024-03-18 | Berkowitz Noah | Buy | 0 | |
2024-02-29 | Teel Randy | Sell | 0 | Common Stock |
2024-02-29 | Teel Randy | Sell | 0 | Common Stock |
INSIDER POWER |
---|
45.30 |
Last 95 transactions |
Buy: 1 590 588 | Sell: 490 115 |
Volumen Correlación
Arvinas Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
WSC | 0.911 |
XMTR | 0.905 |
PRSO | 0.902 |
TRS | 0.899 |
GMBL | 0.898 |
SELB | 0.898 |
SPTN | 0.898 |
AMNB | 0.897 |
ROIC | 0.896 |
ESSA | 0.895 |
10 Correlaciones Más Negativas | |
---|---|
TVTY | -0.902 |
WLTW | -0.898 |
BTAQ | -0.897 |
SGEN | -0.893 |
USLM | -0.891 |
GPACU | -0.887 |
FRSG | -0.885 |
NVSA | -0.883 |
GVCI | -0.883 |
MLAI | -0.881 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Arvinas Inc Correlación - Moneda/Commodity
Arvinas Inc Finanzas
Annual | 2023 |
Ingresos: | $78.50M |
Beneficio Bruto: | $71.80M (91.46 %) |
EPS: | $-6.62 |
FY | 2023 |
Ingresos: | $78.50M |
Beneficio Bruto: | $71.80M (91.46 %) |
EPS: | $-6.62 |
FY | 2022 |
Ingresos: | $131.40M |
Beneficio Bruto: | $123.20M (93.76 %) |
EPS: | $-5.11 |
FY | 2021 |
Ingresos: | $46.00M |
Beneficio Bruto: | $46.00M (100.00 %) |
EPS: | $-3.82 |
Financial Reports:
No articles found.
Arvinas Inc
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico